Skip to main content
KNSA logo

KNSA · Kiniksa Pharmaceuticals International, plc · Analyst Estimates

Track KNSA — free
$93.90 +0.36 (+0.38%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$7.38B
Shares
78.57M
Volume · Nov 20 545.23K Avg daily vol (3M) 658.72K

Analyst Estimates

Compare analyst forecasts for Kiniksa Pharmaceuticals International, plc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-21 18:35 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
1.22
1.47
1.82
4
1.50
1.16
1.16
1.16
0
0
1
1
Revenue
USD
Publication date not stated
1.05B
1.05B
1.05B
7
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
1.59
2.05
2.80
4
2.18
1.62
1.62
1.62
0
0
2
2
Revenue
USD
Publication date not stated
1.29B
1.35B
1.43B
7
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
0.14
0.26
0.41
4
0.28
0.29
0.29
0.29
0
0
1
1
Revenue
USD
Publication date not stated
302.90M
305.04M
306.70M
7
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
0.29
0.39
0.55
4
0.44
0.36
0.36
0.36
0
0
1
1
Revenue
USD
Publication date not stated
310.00M
314.84M
319.20M
5
— — — — — — — —
Key facts CIK 1730430 CUSIP G52694109 13F (30d) 280 filings 272 filers Visit website Investor relations